| Light imaging contrast agents J Klaveness, B Fuglass, P Rongved, E Johannesen, PM Henrichs, ... US Patent 6,159,445, 2000 | 322 | 2000 |
| Diagnostic/therapeutic agents having microbubbles coupled to one or more vectors J Klaveness, P Rongved, A Høgset, H Tolleshaug, A Naevestad, ... US Patent 6,261,537, 2001 | 290 | 2001 |
| Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. SC Wang, MG Wikström, DL White, J Klaveness, E Holtz, P Rongved, ... Radiology 175 (2), 483-488, 1990 | 199 | 1990 |
| Paramagnetic liposomes as MRI contrast agents: influence of liposomal physicochemical properties on the in vitro relaxivity SL Fossheim, AK Fahlvik, J Klaveness, RN Muller Magnetic resonance imaging 17 (1), 83-89, 1999 | 187 | 1999 |
| Microbubble-generating contrast agents for ultrasound and magnetic resonance imaging J Klaveness, P Rongved, L Stubberud US Patent 5,558,856, 1996 | 159 | 1996 |
| Liposomes J Klaveness, A Berg, TV Jacobsen, P Rongved, T Ege, H Kikuchi, K Yachi US Patent 5,676,928, 1997 | 144 | 1997 |
| Contrast agents J Klaveness, H Priebe, P Rongved, L Stubberud US Patent 5,536,490, 1996 | 142 | 1996 |
| Use of fullerenes in diagnostic and/or therapeutic agents AD Watson, J Klaveness, GC Jamieson, JD Fellmann, NB Vogt US Patent 5,688,486, 1997 | 135 | 1997 |
| Light imaging contrast agents J Klaveness, B Fuglass, P Rongved, E Johannesen, PM Hendrichs, ... US Patent 6,540,981, 2003 | 134 | 2003 |
| Targeted ultrasound contrast agents J Klaveness, P Rongved, D Løvhaug US Patent 6,264,917, 2001 | 134 | 2001 |
| Flexible amphiphilic microbubbles for ultrasound J Klaveness, H Priebe, P Rongved, L Stubberud US Patent 5,567,413, 1996 | 133 | 1996 |
| Contrast agents comprising gas-containing or gas-generating polymer microparticles or microballoons J Klaveness, P Rongved, J Solberg, P Strande, UN Wiggen, K Redford US Patent 5,676,925, 1997 | 132 | 1997 |
| Liposomes as carriers of amphiphilic gadolinium chelates: the effect of membrane composition on incorporation efficacy and in vitro relaxivity C Gløgård, G Stensrud, R Hovland, SL Fossheim, J Klaveness International journal of pharmaceutics 233 (1-2), 131-140, 2002 | 126 | 2002 |
| Contrast agents J Klaveness, P Rongved, P Strande US Patent 5,529,766, 1996 | 119 | 1996 |
| Targeted diagnostic/therapeutic agents having more than one different vectors J Klaveness, P Rongved, A Høgset, H Tolleshaug, A Cuthbertson, L Hoff, ... US Patent 6,331,289, 2001 | 109 | 2001 |
| Contrast agents, consisting of carbohydrate particles J Klaveness, P Rongved, L Stubberud US Patent 5,928,626, 1999 | 101 | 1999 |
| Diagnostic/therapeutic agents J Klaveness, P Rongved, A Hogset, H Tolleshaug, A Cuthbertson, ... US Patent App. 10/734,730, 2005 | 99 | 2005 |
| Diagnostic/therapeutic agents J Klaveness, P Rongved, A Høgset, H Tolleshaug, A Cuthbertson, ... US Patent 6,680,047, 2004 | 98 | 2004 |
| Mixture of a positive and negative contrast agent for magnetic resonance imaging A Berg, J Klaveness US Patent 5,128,121, 1992 | 98 | 1992 |
| Gaseous microparticles as ultrasound contrast agents J Klaveness, P Rongved, P Strande US Patent 5,569,449, 1996 | 97 | 1996 |
